ViS (acquired by IQVIA)
New York · Founded 2010
About ViS (acquired by IQVIA)
ViS Research offers a structured online feasibility platform that enables the optimization of clinical trial planning. ViS Research was created by Fabio Thiers, MD, Ph.D. in early 2010. Prior to founding the company, he ran a research program focused on global site allocation at MIT. At that time he learned there was a two-fold challenge: Trial planners spend much time and resources trying to decipher manually gathered information about research centers and the locations where they operate. Research centers, on the other hand, are inefficiently trying to attract trial planners by filling out non-structured requests for information - the so-called "feasibility questionnaires".
Company Facts
- Founded: 2010
- Legal name: VIS Research, Inc.
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $6.2M
- Funding stage: Seed
- Last round: Seed (Jan 2014)
- Website: visresearch.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/vis-acquired-by-iqvia-8373815 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.